Skip to content
Search

Latest Stories

Submit Guest Post

Tata Motors raises £301 million through bonds to refinance debt

INDIAN auto major Tata Motors has raised $425 million (£301m) through unsecured offshore bonds at a rate of 4.35 per cent to refinance existing debt of its subsidiaries.

The company has raised the sum through its wholly-owned arm TML Holdings Pte Ltd (TMLH).


 

TMLH is the holding company of JLR Automotive Plc (JLR), Tata Daewoo, Korea and a few other international operations of Tata Motors.

 

Of the proceeds, Tata will use £225m to refinance existing loans and the rest to meet corporate expenses.

 

"The proceeds from the notes issuance will be used by TMLH for refinancing the outstanding syndicated loan facility of £ 225m, for meeting the issue expenses and for other general corporate purposes," Tata Motors said in a regulatory filing Thursday (3).

 

The "transaction received significant interest from investors across Asia and Europe with the final order book in excess of $2.2 billion (£1.6bn) (representing an oversubscription of over 5.1 times)," the company said.

 

Earlier this year, Jaguar Land Rover announced a new global strategy, Reimagine, under which the company will reposition and redesign Jaguar as an all-electric luxury car brand by 2025.

 

As part of the strategy, Land Rover will also evolve as a manufacturer of luxury electric sports utility vehicles globally.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cervical -cancer-hpv-vaccine

HPV is the most common sexually transmitted infection

Photo for representation: iStock

HPV vaccine reduces cervical cancer deaths to near zero, study finds

Highlights

  • No women aged 20–24 died from cervical cancer in England between 2020 and 2024
  • HPV vaccination is estimated to have prevented nearly 200 deaths among young women
  • Study provides first direct evidence linking HPV vaccination to reduced cervical cancer mortality
  • Vaccine introduced for girls in 2008 in the UK
  • Researchers say higher vaccination uptake is needed to protect future gains

THE HPV vaccine for cervical cancer has reduced the risk of dying from the disease before the age of 30 in England to almost zero, the first study of its kind showed on Thursday (18).

Keep ReadingShow less